Search

everythinglearnresearchcommunity

for

Search:↓

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

PRP shows promise in musculoskeletal rehabilitation but needs standardized reporting for better outcomes.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

PRP shows promise in healing but needs a standardized, safe preparation method.

Some autistic children may have higher levels of male hormones, which could be linked to aggression.

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

The document compares oral-maxillofacial surgery training in Thailand, France, and Germany, highlighting differences in curriculum focus and medical rotations.

PRP and stem cells can help treat baldness by promoting hair growth.

PRP hair treatment is generally safe but may cause minor pain, bleeding, redness, and scalp tightness, and isn't suitable for everyone.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

PRP shows promise for hair loss treatment, but needs standardized preparation and composition.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.